NCT03836209 2025-06-15
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
PrECOG, LLC.
Phase 2 Active not recruiting
PrECOG, LLC.
Stichting Hemato-Oncologie voor Volwassenen Nederland
The First Affiliated Hospital of Soochow University